9,512
Views
58
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

Avelumab (Anti-PD-L1) in Platinum-Resistant/Refractory Ovarian Cancer: JAVELIN Ovarian 200 Phase III Study Design

, , , &
Pages 2103-2113 | Received 24 Jan 2018, Accepted 09 Mar 2018, Published online: 27 Mar 2018